Thaddeus Dryja, M.D.
Dr. Dryja specializes in ophthalmology and is recognized for his 1986 discovery of the Rb tumor suppressor gene, mutations in which lead to a cancer of the eye known as retinoblastoma. He was elected to the National Academy of Sciences in 1996, and currently is Professor of Ophthalmology at Harvard Medical School. Dr. Dryja also leads a research group at the Massachusetts Eye and Ear Infirmary in Boston, Massachusetts.
Page last updated: September 24, 2018